tert-Butyl methyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)carbamate

Catalog No. :
ACZJEB952
CAS No. :
2803922-63-4
Molecular Formula :
C18H29BN2O4
Molecular Weight :
348.25

IUPAC Name:tert-butyl methyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)carbamate

tert-Butyl methyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$666.00Login to see priceInquiryInquiry
100mg95%$863.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl methyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)carbamate
IUPAC Nametert-butyl methyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)carbamate
Molecular FormulaC18H29BN2O4
Molecular Weight348.25
SMILESO=C(N(CC1=NC=CC(B2OC(C)(C(C)(C)O2)C)=C1)C)OC(C)(C)C
InChI KeyAAKYPVRTFGOMNI-UHFFFAOYSA-N
Synonym1,1-Dimethylethyl N-methyl-N-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]methyl]carbamate;tert-Butyl methyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)carbamate
CAS No.2803922-63-4

Synthetic Route by SureRoute

1. ACZJEB952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZJEB952 route product structure diagram
    ACZJEB9522803922-63-4
Inquiry

2. ACZJEB952 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZJEB952 route product structure diagram
    ACZJEB9522803922-63-4
Inquiry

Comments (0)